New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 30, 2014
07:45 EDTMDSOMedidata Solutions price target raised to $55 from $47 at Stifel
Stifel increased its price target on Medidata as the firm thinks the company has a strong platform and robust analytics. The firm believes the company has a number of other positive catalysts and is well-positioned to deliver strong growth. Stifel expects the company to report favorable Q2 results and keeps a Buy rating on the shares.
News For MDSO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 26, 2014
06:34 EDTMDSOMedidata wire fraud should not impact business, says JPMorgan
Subscribe for More Information
September 25, 2014
17:15 EDTMDSOMedidata Solutions subject of international wire transfer fraud
Subscribe for More Information
September 24, 2014
11:42 EDTMDSOMedidata Solutions COO appointment positive, says JPMorgan
JPMorgan views Medidata's addition of Michael Capone in the newly created role of COO as a positive, as Capone should be able to help the company scale and should free up the company's CEO and President to focus on strategy and big deals. The firm maintains its Overweight rating on the stock.
08:36 EDTMDSOMedidata Solutions names Capone COO
Subscribe for More Information
September 17, 2014
10:00 EDTMDSOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:43 EDTMDSOMedidata Solutions initiated with an Overweight at JPMorgan
JPMorgan believes software dedicated to the clinical trial process will be in high demand for years to come. The firm started shares of Medidata Solutions with an Overweight rating and $60 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use